In addition, USP6-associated soft tissue tumors with bone metaplasia need to be differentiated from other osteogenic sarcomas, such as malignant peripheral nerve sheath tumors with heterogeneous bone differentiation and dedifferentiated liposarcomas with heterogeneous bone differentiation. This evidence concerns the gene USP6 and sarcoma.